Generic Name and Formulations:
Diatrizoate meglumine 300mg/mL; soln for inj; contains organically bound iodine 141mg/mL.
Indications for CYSTOGRAFIN:
Take laxative night before exam; low residue diet day before. Individualize. Fill bladder with 25–300mL depending on age of patient and degree of bladder irritability; >300mL may be used if bladder capacity allows.
Severe sensitivity reactions may occur; have emergency equipment available. Bronchial asthma. Significant allergies. Active UTI. Pregnancy (Cat.C).
May interfere with urine specimens.
Radiopaque contrast agent.
Hypersensitivity reactions, hypothyroidism.
Bottles (100mL, 300mL)—1; Dilute (300mL)—10
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- Psychological Therapies May Help Older Adults With Chronic Pain
- Traumatic Brain Injury Linked to Increased Parkinson Disease Risk in Veterans
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics